Shaobo Ke

624 total citations
24 papers, 390 citations indexed

About

Shaobo Ke is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Shaobo Ke has authored 24 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Shaobo Ke's work include Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Shaobo Ke is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Shaobo Ke collaborates with scholars based in China, Netherlands and Japan. Shaobo Ke's co-authors include Hu Qiu, Yongshun Chen, Jiamei Chen, Wei Shi, Wensi Zhao, Yi Gong, Yongshun Chen, Lin Wu, Wei Shi and Qiushuang Wang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gene.

In The Last Decade

Shaobo Ke

24 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaobo Ke China	13	198	131	126	118	93	24	390
Benjamin A. Mooso United States	10	176 0.9×	91 0.7×	123 1.0×	56 0.5×	65 0.7×	16	330
Shigekatsu Maekawa Japan	10	119 0.6×	92 0.7×	117 0.9×	90 0.8×	72 0.8×	54	302
Chien‐Hsing Lin Taiwan	10	116 0.6×	89 0.7×	69 0.5×	74 0.6×	96 1.0×	21	366
Jukka Kallio Finland	11	138 0.7×	102 0.8×	79 0.6×	243 2.1×	39 0.4×	20	425
Chen-Sung Lin Taiwan	9	207 1.0×	30 0.2×	89 0.7×	96 0.8×	119 1.3×	11	354
Maxime Chénard-Poirier United Kingdom	11	144 0.7×	178 1.4×	83 0.7×	23 0.2×	79 0.8×	30	355
Ivan Tomasi United Kingdom	7	167 0.8×	62 0.5×	31 0.2×	76 0.6×	46 0.5×	14	290
Shaohan Wu China	10	190 1.0×	99 0.8×	42 0.3×	39 0.3×	109 1.2×	20	320
Alice Giacobino Italy	10	111 0.6×	242 1.8×	47 0.4×	51 0.4×	81 0.9×	10	358

Countries citing papers authored by Shaobo Ke

Since Specialization

Citations

This map shows the geographic impact of Shaobo Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobo Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobo Ke more than expected).

Fields of papers citing papers by Shaobo Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaobo Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobo Ke. The network helps show where Shaobo Ke may publish in the future.

Co-authorship network of co-authors of Shaobo Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Shaobo Ke. A scholar is included among the top collaborators of Shaobo Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaobo Ke. Shaobo Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Hai‐Meng, et al.. (2025). CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer. Cancer Research. 85(23). 4734–4750. 2 indexed citations

Qiu, Hu, Lijuan Gao, Shi Wei, et al.. (2024). Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway. Cancer Letters. 611. 217401–217401. 1 indexed citations

Zhao, Wensi, Shaobo Ke, Xiaojun Cai, et al.. (2023). Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial. Radiotherapy and Oncology. 184. 109679–109679. 18 indexed citations

Zhao, Wensi, Jun Lei, Shaobo Ke, et al.. (2023). Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215). EClinicalMedicine. 66. 102315–102315. 66 indexed citations

Tian, Yuanyuan, Shaobo Ke, Hu Qiu, et al.. (2023). A Comparison of Clinicopathologic Outcomes and Patterns of Lymphatic Spread Across Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy, and Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 31(2). 860–871. 12 indexed citations

Qiu, Hu, Shaobo Ke, Yong Wu, et al.. (2022). An exploratory clinical trial of apatinib combined with intensity‐modulated radiation therapy for patients with unresectable hepatocellular carcinoma. Cancer Medicine. 12(1). 213–222. 6 indexed citations

Zhu, Xiaojuan, et al.. (2021). Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses. Radiotherapy and Oncology. 164. 236–244. 9 indexed citations

Wang, Jun, Bingwen Zou, Wensi Zhao, et al.. (2021). Preoperative Chemotherapy for Limited-stage Small Cell Carcinoma of the Esophagus. The Annals of Thoracic Surgery. 114(4). 1220–1228. 7 indexed citations

Qiu, Hu, Man Luo, Shaobo Ke, et al.. (2021). Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation. Cancer Cell International. 21(1). 466–466. 4 indexed citations

10.

Wang, Jing, Qiushuang Wang, Yi Gong, et al.. (2021). Knockdown of circRNA circ_0087378 Represses the Tumorigenesis and Progression of Esophageal Squamous Cell Carcinoma Through Modulating the miR-140-3p/E2F3 Axis. Frontiers in Oncology. 10. 607231–607231. 21 indexed citations

11.

Dong, Ke, Qiushuang Wang, Shaobo Ke, Li Zou, & Qi Wang. (2019). Long-Non Coding RNA SNHG16 Supports Colon Cancer Cell Growth by Modulating miR-302a-3p/AKT Axis. Pathology & Oncology Research. 26(3). 1605–1613. 21 indexed citations

12.

Ke, Shaobo, Hu Qiu, Jiamei Chen, et al.. (2019). ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p. Pathology - Research and Practice. 216(3). 152761–152761. 33 indexed citations

13.

Chen, Yongshun, Abraham J. Wu, Geoffrey Y. Ku, et al.. (2019). Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases. Journal of Thoracic Disease. 11(4). 1536–1545. 19 indexed citations

14.

Chen, Yongshun, Xiao‐Yuan Wu, Lei Zhang, et al.. (2018). Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma. Oncotarget. 10(40). 4069–4078. 8 indexed citations

15.

Ke, Shaobo, Hu Qiu, Jiamei Chen, Wei Shi, & Yongshun Chen. (2018). Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases. Current Medical Science. 38(6). 1062–1068. 16 indexed citations

16.

Ke, Shaobo, Hu Qiu, Jiamei Chen, Wei Shi, & Yongshun Chen. (2018). MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1. Gene. 676. 329–335. 27 indexed citations

17.

Chen, Yongshun, et al.. (2017). With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II–III squamous cell carcinoma of the esophagus: A propensity score-matched analysis. Radiotherapy and Oncology. 129(1). 154–160. 16 indexed citations

18.

Yang, Hui, Lin Wu, Shaobo Ke, et al.. (2016). Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells. Journal of Cancer. 7(9). 1152–1162. 25 indexed citations

19.

Ke, Shaobo, Fuxiang Zhou, Hui Yang, et al.. (2014). Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells. International Journal of Oncology. 46(3). 1051–1058. 52 indexed citations

20.

Pan, Gaofeng, Shaobo Ke, & Jinping Zhao. (2013). Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Targeted Oncology. 8(2). 107–116. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact